Article | October 25, 2019

5 Strategies For APAC Drug Submissions: Korea, China, Japan

Source: TransPerfect
Three Major US Manufacturers Of Nutritional Supplements Have Installed Tri-Flows To Control Flotation Dusts From Bagging, Bottling Or Dry Mixing Operations

Korea, China, and Japan are no strangers to clinical trials in Asia. They have large patient populations and sophisticated regulatory systems and infrastructure, and each has worked to adopt the CTD or eCTD for submissions. That said, they also require the most content to be presented in-language to local regulators. So how do you manage up to five million words of critical content translation across 330 files and submit on time?

In July, TransPerfect presented at Bio Asia-Taiwan’s One-on-One Partnering” event, where the hot topic facing Taiwan’s booming biotech industry was “How can we get our drugs registered in China quickly?” Continue reading to learn more from Alicja Borek (Senior Director, Asia), Wei Du (Director, China Strategy), and Silas Chen (Account Management, Taiwan) as they presented a five-point plan to enable smoother submissions.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: